FDA trips up Zosano Pharma's migraine patch 3 weeks before approval date

The company's stock lost more than half its value in after-hours trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.